These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Treatment efficacy for adult persistent immune thrombocytopenia: a systematic review and network meta-analysis. Puavilai T; Thadanipon K; Rattanasiri S; Ingsathit A; McEvoy M; Attia J; Thakkinstian A Br J Haematol; 2020 Feb; 188(3):450-459. PubMed ID: 31423574 [TBL] [Abstract][Full Text] [Related]
6. Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study. Zaja F; Barcellini W; Cantoni S; Carpenedo M; Caparrotti G; Carrai V; Di Renzo N; Santoro C; Di Nicola M; Veneri D; Simonetti F; Liberati AM; Ferla V; Paoloni F; Crea E; Volpetti S; Tuniz E; Fanin R Am J Hematol; 2016 May; 91(5):E293-5. PubMed ID: 26910388 [TBL] [Abstract][Full Text] [Related]
7. Successful treatment of eltrombopag-resistant refractory immune thrombocytopenia with romiplostim. Nakazato T; Ito C; Mihara A; Aisa Y Int J Hematol; 2013 Feb; 97(2):291-3. PubMed ID: 23275229 [No Abstract] [Full Text] [Related]
8. [Successful switching from eltrombopag to romiplostim in a pediatric patient with refractory chronic ITP]. Mori M; Kato M; Koh K; Hanada R Rinsho Ketsueki; 2015 May; 56(5):511-3. PubMed ID: 26062675 [TBL] [Abstract][Full Text] [Related]
9. The efficacy of romiplostim in the treatment of severe thrombocytopenia associated to Evans syndrome refractory to rituximab. Gonzalez-Nieto JA; Martin-Suarez I; Quattrino S; Ortiz-Lopez E; Muñoz-Beamud FR; Colchero-Fernández J; Alcoucer-Diaz MR Lupus; 2011 Oct; 20(12):1321-3. PubMed ID: 21719526 [TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in Ireland. Lee D; Thornton P; Hirst A; Kutikova L; Deuson R; Brereton N Appl Health Econ Health Policy; 2013 Oct; 11(5):457-69. PubMed ID: 23857462 [TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids promote response to thrombopoietin-receptor agonists in refractory ITP: a case series. Poston JN; Gernsheimer TB Int J Hematol; 2019 Aug; 110(2):255-259. PubMed ID: 30972617 [TBL] [Abstract][Full Text] [Related]
12. Primary immune thrombocytopenia in adults: clinical practice versus management guidelines. Ng T; Gatt A; Smith M Postgrad Med J; 2017 Nov; 93(1105):645-646. PubMed ID: 28720688 [No Abstract] [Full Text] [Related]
13. What is publication? The case of eltrombopag. Benham L; Guo L; Turner R Lancet; 2011 Jan; 377(9763):360-1. PubMed ID: 21277427 [No Abstract] [Full Text] [Related]
14. Immune thrombocytopenia successfully treated with eltrombopag following multiple therapies including romiplostim. Sartori R; Candiotto L; Ruggeri M; Tagariello G Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s151-2. PubMed ID: 24120607 [No Abstract] [Full Text] [Related]
15. Positioning new treatments in the management of immune thrombocytopenia. Arnold DM Pediatr Blood Cancer; 2013; 60 Suppl 1(Suppl 1):S19-22. PubMed ID: 23109488 [TBL] [Abstract][Full Text] [Related]
16. Treating chemotherapy-induced thrombocytopenia: is it time for oncologists to use thrombopoietin agonists? Hassan MN; Waller EK Oncology (Williston Park); 2015 Apr; 29(4):295-6. PubMed ID: 25952493 [No Abstract] [Full Text] [Related]
17. Thrombocytopenia: optimizing approaches in cancer patients. Piatek C; Akhtari M Oncology (Williston Park); 2015 Apr; 29(4):297-8. PubMed ID: 25952494 [No Abstract] [Full Text] [Related]
18. Combined romiplostim and intravenous immunoglobulin therapy increased platelet count, facilitating splenectomy in a patient with refractory immune thrombocytopenic purpura unresponsive to monotherapy. Mitsuhashi K; Ishiyama M; Imai Y; Shiseki M; Mori N; Teramura M; Seshimo A; Motoji T Br J Haematol; 2012 Sep; 158(6):798-800. PubMed ID: 22758388 [No Abstract] [Full Text] [Related]
19. Safety and efficacy of romiplostim in patients with eltrombopag-resistant or -intolerant immune thrombocytopenia. Tsukamoto S; Nakaseko C; Takeuchi M; Kumagai K; Komatsu T; Tanaka H; Hara S; Koizumi M; Imai H; Yokota A; Takeuchi M; Inokuchi K; Matsuura Y; Aotsuka N; Wakita H Br J Haematol; 2013 Oct; 163(2):286-9. PubMed ID: 23862773 [No Abstract] [Full Text] [Related]
20. [Recent advances in the treatment of idiopathic thrombocytopenic purpura]. Kurata Y Rinsho Ketsueki; 2007 May; 48(5):355-62. PubMed ID: 17571579 [No Abstract] [Full Text] [Related] [Next] [New Search]